{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T16:30:04Z","timestamp":1789921804551,"version":"4.0.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2009,5,12]],"date-time":"2009-05-12T00:00:00Z","timestamp":1242086400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1038\/sj.bjc.6605086","type":"journal-article","created":{"date-parts":[[2009,5,12]],"date-time":"2009-05-12T20:11:03Z","timestamp":1242159063000},"page":"1824-1831","source":"Crossref","is-referenced-by-count":96,"title":["Ovulation-stimulation drugs and cancer risks: a long-term follow-up of a British cohort"],"prefix":"10.1038","volume":"100","author":[{"given":"I","family":"dos Santos Silva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P A","family":"Wark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V A","family":"McCormack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Overton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Little","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Nieto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Hardiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A B","family":"MacLean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,5,12]]},"reference":[{"key":"BF6605086_CR1","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1093\/aje\/kwi084","volume":"161","author":"MD Althuis","year":"2005","unstructured":"Althuis MD, Moghissi KS, Westhoff CL, Scoccia B, Lamb EJ, Lubin JH, Brinton LA (2005) Uterine cancer after use of clomiphene citrate to induce ovulation. Am J Epidemiol 161: 607\u2013615","journal-title":"Am J Epidemiol"},{"key":"BF6605086_CR2","volume-title":"Statistical Methods in Cancer Research. Volume II- The Design and Analysis of Cohort Studies","author":"NE Breslow","year":"1987","unstructured":"Breslow NE, Day NE (1987) Statistical Methods in Cancer Research. Volume II- The Design and Analysis of Cohort Studies. IARC: Lyon"},{"key":"BF6605086_CR3","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1097\/01.AOG.0000128139.92313.74","volume":"103","author":"LA Brinton","year":"2004","unstructured":"Brinton LA, Lamb EJ, Moghissi KS, Scoccia B, Althuis MD, Mabie JE, Westhoff CL (2004) Ovarian cancer risk after the use of ovulation-stimulating drugs. Obstet Gynecol 103: 1194\u20131203","journal-title":"Obstet Gynecol"},{"key":"BF6605086_CR4","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/S0015-0282(02)04950-6","volume":"79","author":"RT Burkman","year":"2003","unstructured":"Burkman RT, Tang MT, Malone KE, Marchbanks PA, McDonald JA, Folger SG, Norman SA, Strom BL, Bernstein L, Ursin G, Weiss LK, Daling JR, Simon MS, Spirtas R (2003) Infertility drugs and the risk of breast cancer: findings from the National Institute of Child Health and Human Development Women's Contraceptive and Reproductive Experiences Study. Fertil Steril 79: 844\u2013851","journal-title":"Fertil Steril"},{"issue":"3","key":"BF6605086_CR5","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1093\/aje\/kwn318","volume":"169","author":"R. Calderon-Margalit","year":"2008","unstructured":"Calderon-Margalit R, Friedlander Y, Yanetz R, Kleinhaus K, Perrin MC, Manor O, Harlap S, Paltiel O (2008) Cancer risks after exposure to treatment for ovulation induction. Am J Epidemiol doi:10.1093\/aje\/kwn318","journal-title":"American Journal of Epidemiology"},{"key":"BF6605086_CR6","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1136\/bmj.299.6704.886","volume":"299","author":"V Carstairs","year":"1989","unstructured":"Carstairs V, Morris R (1989) Deprivation: explaining differences in mortality between Scotland and England and Wales. Br Med J 299: 886\u2013889","journal-title":"Br Med J"},{"key":"BF6605086_CR7","volume-title":"Statistical Methods in Epidemiology","author":"D Clayton","year":"1993","unstructured":"Clayton D, Hills M (1993) Statistical Methods in Epidemiology. Oxford University Press: Oxford"},{"key":"BF6605086_CR8","unstructured":"Committee on Safety of Medicines (1995) Current problems in pharmaco-vigilance. 21: 7"},{"key":"BF6605086_CR9","unstructured":"Department of the Environment, Transport and the Regions (DETR) (2000) Measuring Multiple Deprivation at the Small Area Level \u2013 The Indices of Deprivation 2000. The Stationery Office: London"},{"key":"BF6605086_CR10","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1093\/humrep\/17.8.2209","volume":"17","author":"P Doyle","year":"2002","unstructured":"Doyle P, Maconochie N, Beral V, Swerdlow AJ, Tan SL (2002) Cancer incidence following treatment for infertility at a clinic in the UK. Hum Reprod 17: 2209\u20132213","journal-title":"Hum Reprod"},{"key":"BF6605086_CR11","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1056\/NEJM197602262940904","volume":"294","author":"HA Edmondson","year":"1976","unstructured":"Edmondson HA, Henderson B, Benton B (1976) Liver cell adenomas associated with the use of oral contraceptive. N Engl J Med 294: 470\u2013472","journal-title":"N Engl J Med"},{"key":"BF6605086_CR12","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1136\/bmj.299.6694.309","volume":"299","author":"S Fishel","year":"1989","unstructured":"Fishel S, Jackson P (1989) Follicular stimulation for high tech pregnancies: are we playing it safe? Br Med J 299: 309\u2013311","journal-title":"Br Med J"},{"key":"BF6605086_CR13","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3109\/09513599109049942","volume":"5","author":"J Ginsburg","year":"1991","unstructured":"Ginsburg J, Hardiman P (1991) Ovulation induction with human menopausal gonadotrophins \u2013 a changing scene. Gynaecol Endocrinol 5: 57\u201378","journal-title":"Gynaecol Endocrinol"},{"key":"BF6605086_CR14","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1093\/biomet\/81.3.515","volume":"81","author":"PM Grambsch","year":"1994","unstructured":"Grambsch PM, Therneau TM (1994) Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 81: 515\u2013526","journal-title":"Biometrika"},{"key":"BF6605086_CR15","unstructured":"Human Fertilisation Embryology Authority (HFEA) (2008) Facts and Figures 2006 2006. Fertility Problems and Treatment, http:\/\/www.hfea.gov.uk\/1269.html#1278 (accessed 22 April 2009)"},{"key":"BF6605086_CR16","unstructured":"International Agency for Research on Cancer (IARC) (1999) IARC Monographs: Hormonal contraception and post-menopausal hormonal therapy Vol. 72, p 293. IARC Press: Lyon"},{"key":"BF6605086_CR17","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1002\/ijc.21953","volume":"119","author":"International Collaboration of Epidemiological Studies of Cervical Cancer (ICESCC)","year":"2006","unstructured":"International Collaboration of Epidemiological Studies of Cervical Cancer (ICESCC) (2006) Cervical carcinoma and reproductive factors: collaborative reanalysis of individual data on 16\u2009563 women with cervical carcinoma and 33\u2009542 women without cervical carcinoma from 25 epidemiological studies. Int J Cancer 119: 1108\u20131124","journal-title":"Int J Cancer"},{"key":"BF6605086_CR18","doi-asserted-by":"publisher","first-page":"b249","DOI":"10.1136\/bmj.b249","volume":"338","author":"A Jensen","year":"2009","unstructured":"Jensen A, Sharif H, Frederiksen K, Kjaer SK (2009) Use of fertility drugs and risk of ovarian cancer: Danish Population Based Cohort Study. Br Med J 338: b249 doi: 10.1136\/bmj.b249","journal-title":"Br Med J"},{"key":"BF6605086_CR19","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1158\/1055-9965.EPI-07-0075","volume":"16","author":"A Jensen","year":"2007","unstructured":"Jensen A, Sharif H, Scare EI, Frederiksen K, Kr\u00fcger Kj\u00e6r S (2007) Risk of breast cancer after exposure to fertility drugs: results from a large Danish cohort study. Cancer Epidemiol Biomarkers Prev 16: 1400\u20131407","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"BF6605086_CR20","first-page":"55","volume-title":"Long-term health effects of subfertility treatment","author":"H Klip","year":"2002","unstructured":"Klip H, Burger CW, van Leeuwen FE, the OMEGA Project Group (2002) Risk of hormone-related cancers after ovarian stimulation for in-vitro fertilisation in a cohort of 25\u2009152 women. In Long-term health effects of subfertility treatment Klip H (ed.) 55\u201380. PrintPartners Ipskamp BV: Enschede, The Netherlands"},{"key":"BF6605086_CR21","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1023\/A:1008832513932","volume":"10","author":"C La Vecchia","year":"1999","unstructured":"La Vecchia C, Ron E, Franceschi S, Dal Maso L, Mark SD, Chatenoud L, Braga C, Preston-Martin S, McTiernan A, Kolonel L, Mabuchi K, Jin F, Wingren G, Galanti MR, Hallquist A, Lund E, Levi F, Linos D, Negri E (1999) A pooled analysis of case-control studies of thyroid cancer. III. Oral contraceptives, menopausal replacement therapy and other female hormones. Cancer Causes Control 10: 157\u2013166","journal-title":"Cancer Causes Control"},{"key":"BF6605086_CR22","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1093\/oxfordjournals.aje.a009397","volume":"147","author":"B Modan","year":"1998","unstructured":"Modan B, Ron E, Lerner-Geva L, Blumstein T, Menczer J, Rabinovici J, Oelsner G, Freedman L, Mashiach S, Lunenfeld B (1998) Cancer incidence in a cohort of infertile women. Am J Epidemiol 147: 1038\u20131042","journal-title":"Am J Epidemiol"},{"key":"BF6605086_CR23","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1093\/aje\/155.3.217","volume":"155","author":"RB Ness","year":"2003","unstructured":"Ness RB, Cramer DW, Goodman MT, Kjaer SK, Mallin K, Mosgaard BJ, Purdie DM, Risch HA, Vergona R, Wu AH (2003) Infertility, fertility drugs, and ovarian cancer: a pooled analysis of case-control studies. Am J Epidemiol 155: 217\u2013224","journal-title":"Am J Epidemiol"},{"key":"BF6605086_CR24","unstructured":"Office of Population Census and Surveys (OPCS) (1991) Standard Occupational Classification Volume 3. HMSO: London"},{"key":"BF6605086_CR25","unstructured":"Office of Population Census and Surveys (OPCS) & General Register Office (GRO) for Scotland (1993) Report for Great Britain. Part 2. HMSO: London"},{"key":"BF6605086_CR26","doi-asserted-by":"crossref","unstructured":"Org\u00e9as CC, Sanner K, Hall P, Conner P, Holte J, Nilsson SJ, Sundfelt K, Persson I, Seng Chia K, Wedren S, Dickman PW, Czeme K (2009) Breast acncer incidence after hormonal infertility tretament in Sweden: a cohort study. Am J Obstet Gynecol 200, 72. e1\u201372.e7","DOI":"10.1016\/j.ajog.2008.08.066"},{"key":"BF6605086_CR27","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1093\/humrep\/14.6.1653","volume":"14","author":"E Ricci","year":"1999","unstructured":"Ricci E, Parazzini F, Negri E, Marsico S, La Vecchia C (1999) Fertility drugs and the risk of breast cancer. Hum Reprod 14: 1653\u20131655","journal-title":"Hum Reprod"},{"key":"BF6605086_CR28","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1093\/oxfordjournals.aje.a114595","volume":"125","author":"E Ron","year":"1987","unstructured":"Ron E, Lunenfeld B, Menczer J, Blumstein T, Katz L, Oelsner G, Serr D (1987) Cancer incidence in a cohort of infertile women. Am J Epidemiol 125: 780\u2013790","journal-title":"Am J Epidemiol"},{"key":"BF6605086_CR29","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1056\/NEJM199409223311204","volume":"331","author":"MA Rossing","year":"1994","unstructured":"Rossing MA, Daling JR, Weiss NS, Moore DE, Self SG (1994) Ovarian tumors in a cohort of infertile women. New Eng J Med 331: 771\u2013776","journal-title":"New Eng J Med"},{"key":"BF6605086_CR30","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1097\/00008390-199504000-00009","volume":"5","author":"MA Rossing","year":"1995","unstructured":"Rossing MA, Daling JR, Weiss NS, Moore DE, Self SG (1995) Risk of cutaneous melanoma in a cohort of infertile women. Melanoma Res 5: 123\u2013127","journal-title":"Melanoma Res"},{"key":"BF6605086_CR31","first-page":"23:18","volume":"4","author":"P Sasieni","year":"1995","unstructured":"Sasieni P (1995) Tabulation of observed\/expected rations and confidence intervals. Stata Technical Bulletin 4: 23:18\u201323:20","journal-title":"Stata Technical Bulletin"},{"key":"BF6605086_CR32","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1093\/biomet\/69.1.239","volume":"69","author":"DA Schoenfeld","year":"1982","unstructured":"Schoenfeld DA (1982) Partial residuals for the proportional hazards regression model. Biometrika; 69: 239\u2013241","journal-title":"Biometrika;"},{"key":"BF6605086_CR33","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0015-0282(16)58020-0","volume":"65","author":"A Shushan","year":"1996","unstructured":"Shushan A, Paltiel O, Iscovich T, Elchalal U, Peretz T, Schenker JG (1996) Human menopausal gonadotrophin and the risk of epithelial ovarian cancer. Fertil Steril 65: 13\u201318","journal-title":"Fertil Steril"},{"key":"BF6605086_CR34","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1093\/jnci\/dji057","volume":"97","author":"AJ Swerdlow","year":"2005","unstructured":"Swerdlow AJ, Jones ME, British Tamoxifen Second Cancer Study Group (2005) Tamoxifen treatment for breast cancer and risk of endometrial cancer: a case-control study. J Natl Cancer Inst 97: 375\u2013384","journal-title":"J Natl Cancer Inst"},{"key":"BF6605086_CR35","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1016\/S0140-6736(99)05203-4","volume":"354","author":"A Venn","year":"1999","unstructured":"Venn A, Watson L, Bruinsma F, Giles G, Healy D (1999) Risk of cancer after use of fertility drugs with in-vitro fertilisation. Lancet 354: 1586\u20131590","journal-title":"Lancet"},{"key":"BF6605086_CR36","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/S0140-6736(95)91687-3","volume":"346","author":"A Venn","year":"1995","unstructured":"Venn A, Watson L, Lumley J, Giles G, King C, Healy D (1995) Breast and ovarian cancer incidence after infertility and in vitro fertilisation. Lancet 346: 995\u20131000","journal-title":"Lancet"},{"key":"BF6605086_CR37","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1023\/A:1008881305738","volume":"9","author":"HA Weiss","year":"1998","unstructured":"Weiss HA, Troisi R, Rossing MA, Brogan D, Coates RJ, Gammon MD, Potischman N, Swanson CA, Brinton LA (1998) Fertility problems and breast cancer risk in young women: a case-control study in the United States. Cancer Causes Control 9: 331\u2013339","journal-title":"Cancer Causes Control"},{"key":"BF6605086_CR38","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1093\/oxfordjournals.aje.a116427","volume":"136","author":"AS Whittemore","year":"1992","unstructured":"Whittemore AS, Harris R, Itnyre J, Collaborative Ovarian Cancer Group (1992) Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancer in white women. Am J Epidemiol 136: 1184\u20131203","journal-title":"Am J Epidemiol"},{"key":"BF6605086_CR39","unstructured":"World Health Organisation (1957, 1967, 1977, 1994) Manual of the International Statistical Classification of Diseases, Injuries and Causes of Death, seventh, eight, ninth and tenth revisions. World Health Organisation: Geneva"},{"key":"BF6605086_CR40","unstructured":"World Health Organisation (1973) Advances in methods of fertility regulation: report of a WHO scientific group. World Health Organ Technical Report Ser. 527 1\u201342. World Health Organisation: Geneva"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6605086.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6605086","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6605086.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:39:54Z","timestamp":1684413594000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6605086"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5,12]]},"references-count":40,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["BF6605086"],"URL":"https:\/\/doi.org\/10.1038\/sj.bjc.6605086","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,5,12]]}}}